BRPI0819352A2 - Piperidinas 4,4-dissubstituídas - Google Patents

Piperidinas 4,4-dissubstituídas

Info

Publication number
BRPI0819352A2
BRPI0819352A2 BRPI0819352A BRPI0819352A2 BR PI0819352 A2 BRPI0819352 A2 BR PI0819352A2 BR PI0819352 A BRPI0819352 A BR PI0819352A BR PI0819352 A2 BRPI0819352 A2 BR PI0819352A2
Authority
BR
Brazil
Prior art keywords
disubstituted piperidines
piperidines
disubstituted
Prior art date
Application number
Other languages
English (en)
Inventor
Peter Herold
Robert Mah
Vincenzo Tschinke
Stjepan Jelakovic
Stefan Stutz
Christiane Marti
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of BRPI0819352A2 publication Critical patent/BRPI0819352A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BRPI0819352 2007-11-02 2008-10-31 Piperidinas 4,4-dissubstituídas BRPI0819352A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07119884 2007-11-02
PCT/EP2008/064767 WO2009056617A2 (en) 2007-11-02 2008-10-31 4,4-disubstituted piperdines as renin inhibitors

Publications (1)

Publication Number Publication Date
BRPI0819352A2 true BRPI0819352A2 (pt) 2015-04-22

Family

ID=39204939

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0819352 BRPI0819352A2 (pt) 2007-11-02 2008-10-31 Piperidinas 4,4-dissubstituídas

Country Status (13)

Country Link
US (1) US20100267713A1 (pt)
EP (1) EP2215088A2 (pt)
JP (1) JP2011503022A (pt)
KR (1) KR20100075590A (pt)
CN (1) CN101918398A (pt)
AR (1) AR069145A1 (pt)
AU (1) AU2008320806A1 (pt)
BR (1) BRPI0819352A2 (pt)
CA (1) CA2699889A1 (pt)
EA (1) EA201000720A1 (pt)
MX (1) MX2010004759A (pt)
TW (1) TW200934499A (pt)
WO (1) WO2009056617A2 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2708866A1 (en) 2007-12-19 2009-06-25 Hiroyuki Nakahira Bicyclic heterocyclic derivative
KR20120109292A (ko) 2009-06-24 2012-10-08 다이닛본 스미토모 세이야꾸 가부시끼가이샤 N-치환-시클릭 아미노 유도체
AU2019387370A1 (en) 2018-11-30 2021-06-10 Nuvation Bio Inc. Pyrrole and pyrazole compounds and methods of use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL193686B1 (pl) * 1995-09-07 2007-03-30 Hoffmann La Roche Pochodne piperydyny, środki lecznicze zawierającepochodne piperydyny, sposoby wytwarzania tych pochodnych oraz zastosowanie pochodnych
US6376672B1 (en) * 1999-04-27 2002-04-23 Hoffmann-La Roche Inc. Naphthalenylmethoxypiperidines as renin inhibitors
US6197959B1 (en) * 1999-04-27 2001-03-06 Hoffmann-La Roche Inc. Piperidine derivatives
TW200833687A (en) * 2005-03-31 2008-08-16 Speedel Experimenta Ag Substituted piperidines
TW200804359A (en) * 2006-01-19 2008-01-16 Speedel Experimenta Ag Substituted 4-phenylpiperidines

Also Published As

Publication number Publication date
WO2009056617A2 (en) 2009-05-07
KR20100075590A (ko) 2010-07-02
EP2215088A2 (en) 2010-08-11
EA201000720A1 (ru) 2010-10-29
WO2009056617A3 (en) 2009-07-09
AR069145A1 (es) 2009-12-30
AU2008320806A1 (en) 2009-05-07
CA2699889A1 (en) 2009-05-07
MX2010004759A (es) 2010-05-19
TW200934499A (en) 2009-08-16
CN101918398A (zh) 2010-12-15
US20100267713A1 (en) 2010-10-21
JP2011503022A (ja) 2011-01-27

Similar Documents

Publication Publication Date Title
BRPI0816970A2 (pt) 1,3-dissubstituídas-4-fenil-1h-piridin-2-onas
DK2205562T3 (da) 1,1,1-trifluor-2-hydroxy-3-phenylpropanderivater
DK2610258T3 (da) Substituerede piperidindihydrothienopyrimidiner
ATE469145T1 (de) 4-ä5-methoxy-6-(2-methyl-6-ä1,2,4ütriazol-1-yl-
DK2200985T3 (da) 1,3-Disubstituerede 4-(aryl--X-phenyl)-1H-pyridin-2-oner
ATE506359T1 (de) Heteroaryl-substituierte piperidine
ATE555107T1 (de) 2-aza-bicyclo-ä2,2,1-üheptan-derivate
HRP20151058T1 (xx) Ariloazol-2-il-cijanoetilamino-spojevi, postupak njihove proizvodnje i postupak njihove uporabe
BRPI0923786A2 (pt) compostos 5,6-dihidro-6-fenilbenzo(f) isoquinolina-2- amina substituidos
BRPI0811718A2 (pt) Derivados de 3,3-espiroindolinona
BRPI0914772A2 (pt) compostos heterocíclicos 1,2-dissubstituídos
BRPI0918472A2 (pt) composto 2,4-diaminopirimidina
DE602007009284D1 (de) 3-aza-bicycloä3.1.0ühexanderivate
ATE513831T1 (de) Pyridinä3,4-büpyrazinone
DE502007005077D1 (de) Einklemmschutzvorrichtung
DE602007001681D1 (de) 1,3-dioxan-carboxylsäuren
UY33125A (es) Diaza-espiro-[5,5]-undecanos
BRPI0815059A2 (pt) Derivado de 1,3-di-hidroisoindol
BRPI0817915A2 (pt) Embalagem 043
BRPI1012055A2 (pt) "piperidinas substituídas"
DE602006016573D1 (de) Substituierte piperidine
IL202093A0 (en) 4,4-disubstituted piperidine derivatives
DK2203457T3 (da) Dispiro-1,2,4-trioxolaner som antimalariamidler
IL195631A0 (en) 2,5-disubstituted piperidines
BRPI0916395A2 (pt) compostos de 1,6-di-hidro-2h-3-oxa-6-aza-as-indaceno

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]